-
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease. RMD Open. 2024 Nov 27; 10(4).
Bae SS, Abtin F, Kim G, Markovic D, Chan C, Moghadam-Kia S, Oddis CV, Sullivan D, Marder G, Venuturupalli S, Dellaripa PF, Doyle TJ, Hunninghake GM, Falk J, Charles-Schoeman C, Tashkin DP, Goldin J, Aggarwal R. PMID: 39608864; PMCID: PMC11603737.
View in:
PubMed Mentions: Translation:
Humans
-
Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins. RMD Open. 2024 Oct 26; 10(4).
Razmjou AA, Kremer JM, Pappas DA, Curtis JR, Wang J, Shahbazian A, Elashoff DA, Guo R, Meriwether D, Sulaiman D, O'Connor E, Reddy ST, Charles-Schoeman C. PMID: 39461874; PMCID: PMC11529732.
View in:
PubMed Mentions: Translation:
Humans
-
Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis. Arthritis Rheumatol. 2024 Oct 17.
Baker JF, Reed G, Mikuls TR, Thiele GM, Pappas DA, Charles-Schoeman C, Guma M, Harrold LR, Curtis JR, Kremer JM. PMID: 39420627.
View in:
PubMed Mentions: Fields:
-
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease. Rheumatology (Oxford). 2024 Sep 02.
Bae SS, Markovic D, Saygin D, Sullivan D, Yamaguchi K, Moghadam-Kia S, Oddis CV, Abtin F, Kim GHJ, Marder G, Venuturupalli S, Dellaripa PF, Danoff S, Doyle T, Hunninghake G, Lee JS, Falk J, Johnson C, Goldin J, Tashkin D, Charles-Schoeman C, Aggarwal R. PMID: 39222437.
View in:
PubMed Mentions: Fields:
-
Itch but no rash in dermatomyositis? Treatment of heat-induced pruritic pain syndrome. Rheumatology (Oxford). 2024 Aug 16.
Dente E, Charles-Schoeman C. PMID: 39150474.
View in:
PubMed Mentions: Fields:
-
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study. RMD Open. 2024 07 25; 10(3).
Fleischmann R, Meerwein S, Charles-Schoeman C, Combe B, Hall S, Khan N, Carter KM, Camp HS, Rubbert-Roth A. PMID: 39059811; PMCID: PMC11284939.
View in:
PubMed Mentions:
1 Translation:
HumansCTClinical Trials
-
Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients. Semin Arthritis Rheum. 2024 Oct; 68:152504.
Pappas DA, Reed G, Kane K, Curtis JR, Charles-Schoeman C, Giles JT, Kremer JM. PMID: 38991379.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients. Arthritis Rheumatol. 2024 Aug; 76(8):1218-1229.
Charles-Schoeman C, Fleischmann R, Mysler E, Greenwald M, Ytterberg SR, Koch GG, Bhatt DL, Wang C, Mikuls TR, Chen AS, Connell CA, Woolcott JC, Menon S, Chen Y, Lee K, Szekanecz Z. PMID: 38481002.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study. RMD Open. 2024 04 12; 10(2).
Buch MH, Bhatt DL, Charles-Schoeman C, Giles JT, Mikuls T, Koch GG, Ytterberg S, Nagy E, Jo H, Kwok K, Connell CA, Masri KR, Yndestad A. PMID: 38609322; PMCID: PMC11029242.
View in:
PubMed Mentions:
3 Translation:
HumansCTClinical Trials
-
Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nat Rev Rheumatol. 2024 Mar; 20(3):196.
Szekanecz Z, Buch MH, Charles-Schoeman C, Galloway J, Karpouzas GA, Kristensen LE, Ytterberg SR, Hamar A, Fleischmann R. PMID: 38302658.
View in:
PubMed Mentions: Fields:
-
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study. Arthritis Res Ther. 2024 01 17; 26(1):27.
Aggarwal R, Schessl J, Charles-Schoeman C, Bata-Csörgo Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Beckmann I, Clodi E, Levine T, ProDERM investigators. PMID: 38233885; PMCID: PMC10792872.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCTClinical Trials
-
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nat Rev Rheumatol. 2024 Feb; 20(2):101-115.
Szekanecz Z, Buch MH, Charles-Schoeman C, Galloway J, Karpouzas GA, Kristensen LE, Ytterberg SR, Hamar A, Fleischmann R. PMID: 38216757.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years. Rheumatol Ther. 2024 Feb; 11(1):157-175.
Charles-Schoeman C, Giles JT, Lane NE, Choy E, Furst DE, Vencovský J, Wilson AG, Burmester GR, Coombs D, Penn SK, Khan N, Yee JB, Rahawi K, McInnes IB. PMID: 38180720; PMCID: PMC10796877.
View in:
PubMed Mentions:
-
Correction to: Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis. Clin Rheumatol. 2023 Nov; 42(11):3175.
Razmjou AA, Wang JM, Shahbazian A, Reddy S, Charles-Schoeman C. PMID: 37707640; PMCID: PMC10587016.
View in:
PubMed Mentions: Fields:
-
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. RMD Open. 2023 11; 9(4).
Charles-Schoeman C, Choy E, McInnes IB, Mysler E, Nash P, Yamaoka K, Lippe R, Khan N, Shmagel AK, Palac H, Suboticki J, Curtis JR. PMID: 37945286; PMCID: PMC10649869.
View in:
PubMed Mentions:
8 Translation:
Humans
-
Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM study. EClinicalMedicine. 2023 Oct; 64:102234.
Werth VP, Aggarwal R, Charles-Schoeman C, Schessl J, Levine T, Kopasz N, Worm M, Bata-Csörgo Z. PMID: 37799613; PMCID: PMC10550512.
View in:
PubMed Mentions:
2
-
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib. J Rheumatol. 2023 Jul 15.
Charles-Schoeman C, Hyde C, Guan S, Parikh N, Wang J, Shahbazian A, Stockert L, Andrews J. PMID: 37453736.
View in:
PubMed Mentions:
3 Fields:
-
Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin. Rheumatol Int. 2023 09; 43(9):1629-1636.
Bae SS, Faure-Kumar E, Ferbas K, Wang J, Shahbazian A, Truong L, Yang H, McMahon M, FitzGerald JD, Charles-Schoeman C. PMID: 37368037; PMCID: PMC10348966.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCellsPHPublic Health
-
Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme. Ann Rheum Dis. 2023 09; 82(9):1130-1141.
Fleischmann R, Curtis JR, Charles-Schoeman C, Mysler E, Yamaoka K, Richez C, Palac H, Dilley D, Liu J, Strengholt S, Burmester G. PMID: 37308218; PMCID: PMC10423494.
View in:
PubMed Mentions:
15 Fields:
Translation:
HumansCTClinical Trials
-
Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis. Rheumatol Int. 2023 06; 43(6):1041-1053.
Charles-Schoeman C, Wang J, Shahbazian A, Wilhalme H, Brook J, Kaeley GS, Oganesian B, Ben-Artzi A, Elashoff DA, Ranganath VK. PMID: 36828925; PMCID: PMC10125943.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. Ann Rheum Dis. 2023 04; 82(4):575-577.
Dougados M, Charles-Schoeman C, Szekanecz Z, Giles JT, Ytterberg SR, Bhatt DL, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Connell CA, Yndestad A, Rivas JL, Buch MH. PMID: 36720582; PMCID: PMC10086292.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Trial of Intravenous Immune Globulin in Dermatomyositis. Reply. N Engl J Med. 2023 01 05; 388(1):94-95.
Aggarwal R, Charles-Schoeman C, Schessl J. PMID: 36599070.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. RMD Open. 2022 11; 8(2).
Weitz JI, Szekanecz Z, Charles-Schoeman C, Vranic I, Sahin B, Paciga SA, Wang Z, Hyde C, Martin DA. PMID: 36323490; PMCID: PMC9639150.
View in:
PubMed Mentions:
5 Translation:
Humans
-
Trial of Intravenous Immune Globulin in Dermatomyositis. N Engl J Med. 2022 10 06; 387(14):1264-1278.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgo Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, Magnolo N, Nelson R, Pozur N, Prystupa L, Sárdy M, Valenzuela G, van der Kooi AJ, Vu T, Worm M, Levine T, ProDERM Trial Group. PMID: 36198179.
View in:
PubMed Mentions:
34 Fields:
Translation:
Humans
-
Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis. Clin Rheumatol. 2023 Jan; 42(1):75-82.
Razmjou AA, Wang JM, Shahbazian A, Reddy S, Charles-Schoeman C. PMID: 36138190; PMCID: PMC9823017.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance. Ann Rheum Dis. 2023 01; 82(1):119-129.
Charles-Schoeman C, Buch MH, Dougados M, Bhatt DL, Giles JT, Ytterberg SR, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Rivas JL, Yndestad A, Connell CA, Szekanecz Z. PMID: 36137735; PMCID: PMC9811099.
View in:
PubMed Mentions:
57 Fields:
Translation:
HumansCTClinical Trials
-
Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab. Arthritis Res Ther. 2022 08 25; 24(1):207.
Rubbert-Roth A, Furst DE, Fiore S, Praestgaard A, Bykerk V, Bingham CO, Charles-Schoeman C, Burmester G. PMID: 36008838; PMCID: PMC9404615.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCTClinical Trials
-
Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2022 05 30; 61(6):2512-2523.
Bae SS, Shahbazian A, Wang J, Golub I, Oganesian B, Dowd T, Vayngortin B, Wang R, Elashoff D, Reddy ST, Charles-Schoeman C. PMID: 34698804; PMCID: PMC9308379.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Altered Gut Microbiome in Patients With Dermatomyositis. ACR Open Rheumatol. 2022 Aug; 4(8):658-670.
Bae SS, Dong TS, Wang J, Lagishetty V, Katzka W, Jacobs JP, Charles-Schoeman C. PMID: 35615912; PMCID: PMC9374048.
View in:
PubMed Mentions:
5
-
Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry. Arthritis Care Res (Hoboken). 2021 04; 73(4):471-480.
Curtis JR, Weinblatt M, Saag K, Bykerk VP, Furst DE, Fiore S, St John G, Kimura T, Zheng S, Bingham CO, Wright G, Bergman M, Nola K, Charles-Schoeman C, Shadick N. PMID: 33002337; PMCID: PMC8048846.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus. ACR Open Rheumatol. 2021 Apr; 3(4):209-220.
Skaggs BJ, Grossman J, Sahakian L, Perry L, FitzGerald J, Charles-Schoeman C, Gorn A, Taylor M, Moriarty J, Ragavendra N, Weisman M, Wallace DJ, Hahn BH, McMahon M. PMID: 33605563; PMCID: PMC8063147.
View in:
PubMed Mentions:
15
-
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study"). Medicine (Baltimore). 2021 Jan 08; 100(1):e23677.
Aggarwal R, Charles-Schoeman C, Schessl J, Dimachkie MM, Beckmann I, Levine T. PMID: 33429735; PMCID: PMC7793357.
View in:
PubMed Mentions:
16 Fields:
Translation:
HumansCTClinical Trials
-
High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2020 11 01; 59(11):3515-3525.
Bae SS, Lee YY, Shahbazian A, Wang J, Meriwether D, Golub I, Oganesian B, Dowd T, Reddy ST, Charles-Schoeman C. PMID: 32830270; PMCID: PMC7590404.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCells
-
Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice. Sci Rep. 2020 10 08; 10(1):16848.
Charles-Schoeman C, Wang J, Shahbazian A, Lee YY, Wang X, Grijalva V, Brahn E, Shih DM, Devarajan A, Montano C, Lusis AJ, Reddy ST. PMID: 33033318; PMCID: PMC7546628.
View in:
PubMed Mentions:
9 Fields:
Translation:
HumansAnimalsCells
-
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme. RMD Open. 2020 10; 6(3).
Cohen SB, Tanaka Y, Mariette X, Curtis JR, Lee EB, Nash P, Winthrop KL, Charles-Schoeman C, Wang L, Chen C, Kwok K, Biswas P, Shapiro A, Madsen A, Wollenhaupt J. PMID: 33127856; PMCID: PMC7722371.
View in:
PubMed Mentions:
63 Translation:
HumansCTClinical Trials
-
Major Lipids and Future Risk of Pneumonia: 20-Year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort. Am J Med. 2021 02; 134(2):243-251.e2.
Bae SS, Chang LC, Merkin SS, Elashoff D, Ishigami J, Matsushita K, Charles-Schoeman C. PMID: 32814017; PMCID: PMC7870521.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data. Ann Rheum Dis. 2020 11; 79(11):1400-1413.
Mease P, Charles-Schoeman C, Cohen S, Fallon L, Woolcott J, Yun H, Kremer J, Greenberg J, Malley W, Onofrei A, Kanik KS, Graham D, Wang C, Connell C, Valdez H, Hauben M, Hung E, Madsen A, Jones TV, Curtis JR. PMID: 32759265; PMCID: PMC7569391.
View in:
PubMed Mentions:
87 Fields:
Translation:
Humans
-
Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study. Clin Cardiol. 2020 Jul; 43(7):732-742.
Bae SS, Oganesian B, Golub I, Charles-Schoeman C. PMID: 32432360; PMCID: PMC7368310.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long-Term Extension Studies. Arthritis Care Res (Hoboken). 2019 10; 71(10):1387-1395.
Gladman DD, Charles-Schoeman C, McInnes IB, Veale DJ, Thiers B, Nurmohamed M, Graham D, Wang C, Jones T, Wolk R, DeMasi R. PMID: 31112005; PMCID: PMC6764856.
View in:
PubMed Mentions:
17 Fields:
Translation:
Humans
-
Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2019 09; 71(9):1450-1459.
Charles-Schoeman C, DeMasi R, Valdez H, Soma K, Hwang LJ, Boy MG, Biswas P, McInnes IB. PMID: 31385441; PMCID: PMC6754249.
View in:
PubMed Mentions:
39 Fields:
Translation:
Humans
-
Dr. Charles-Schoeman and E. Bananis Reply. J Rheumatol. 2018 11; 45(11):1605.
Charles-Schoeman C, Bananis E. PMID: 30385698.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Oral cyclophosphamide in treatment of patients with refractory idiopathic inflammatory myopathies: a retrospective observational study. Clin Rheumatol. 2018 Aug; 37(8):2113-2123.
Bae S, Charles-Schoeman C. PMID: 29971584.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis. Atherosclerosis. 2018 08; 275:107-114.
Charles-Schoeman C, Gugiu GB, Ge H, Shahbazian A, Lee YY, Wang X, Furst DE, Ranganath VK, Maldonado M, Lee T, Reddy ST. PMID: 29886354; PMCID: PMC6113060.
View in:
PubMed Mentions:
18 Fields:
Translation:
HumansCTClinical Trials
-
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies. J Rheumatol. 2018 02; 45(2):177-187.
Charles-Schoeman C, van der Heijde D, Burmester GR, Nash P, Zerbini CAF, Connell CA, Fan H, Kwok K, Bananis E, Fleischmann R. PMID: 29142036.
View in:
PubMed Mentions:
8 Fields:
Translation:
HumansCTClinical Trials
-
High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis. Clin Rheumatol. 2018 Mar; 37(3):615-622.
Charles-Schoeman C, Meriwether D, Lee YY, Shahbazian A, Reddy ST. PMID: 29129008; PMCID: PMC6148336.
View in:
PubMed Mentions:
21 Fields:
Translation:
HumansCells
-
Cardiac Transplantation in Dermatomyositis: A case report and literature review. Hum Pathol (N Y). 2017 Jun; 8:55-58.
Bae S, Khanlou N, Charles-Schoeman C. PMID: 29204355; PMCID: PMC5710758.
View in:
PubMed Mentions:
3
-
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials. Ann Rheum Dis. 2017 Jul; 76(7):1253-1262.
Cohen SB, Tanaka Y, Mariette X, Curtis JR, Lee EB, Nash P, Winthrop KL, Charles-Schoeman C, Thirunavukkarasu K, DeMasi R, Geier J, Kwok K, Wang L, Riese R, Wollenhaupt J. PMID: 28143815; PMCID: PMC5530353.
View in:
PubMed Mentions:
162 Fields:
Translation:
Humans
-
Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial. Arthritis Rheumatol. 2017 01; 69(1):46-57.
Charles-Schoeman C, Yin Lee Y, Shahbazian A, Wang X, Elashoff D, Curtis JR, Navarro-Millán I, Yang S, Chen L, Cofield SS, Moreland LW, Paulus H, O'Dell J, Bathon J, Louis Bridges S, Reddy ST. PMID: 27483410; PMCID: PMC5195879.
View in:
PubMed Mentions:
32 Fields:
Translation:
Humans
-
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor. Semin Arthritis Rheum. 2016 12; 46(3):261-271.
Charles-Schoeman C, Wicker P, Gonzalez-Gay MA, Boy M, Zuckerman A, Soma K, Geier J, Kwok K, Riese R. PMID: 27443588.
View in:
PubMed Mentions:
65 Fields:
Translation:
Humans
-
Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist. Semin Arthritis Rheum. 2016 08; 46(1):71-80.
Charles-Schoeman C, Gonzalez-Gay MA, Kaplan I, Boy M, Geier J, Luo Z, Zuckerman A, Riese R. PMID: 27079757.
View in:
PubMed Mentions:
56 Fields:
Translation:
Humans
-
Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheumatol. 2016 Mar; 68(3):577-86.
Charles-Schoeman C, Wang X, Lee YY, Shahbazian A, Navarro-Millán I, Yang S, Chen L, Cofield SS, Moreland LW, O'Dell J, Bathon JM, Paulus H, Bridges SL, Curtis JR. PMID: 26606398; PMCID: PMC4774543.
View in:
PubMed Mentions:
21 Fields:
Translation:
HumansCTClinical Trials
-
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2016 07; 75(7):1293-301.
Charles-Schoeman C, Burmester G, Nash P, Zerbini CA, Soma K, Kwok K, Hendrikx T, Bananis E, Fleischmann R. PMID: 26275429; PMCID: PMC4941182.
View in:
PubMed Mentions:
30 Fields:
Translation:
HumansCTClinical Trials
-
Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib. Arthritis Rheumatol. 2015 03; 67(3):616-25.
Charles-Schoeman C, Fleischmann R, Davignon J, Schwartz H, Turner SM, Beysen C, Milad M, Hellerstein MK, Luo Z, Kaplan IV, Riese R, Zuckerman A, McInnes IB. PMID: 25470338; PMCID: PMC5024065.
View in:
PubMed Mentions:
99 Fields:
Translation:
HumansCTClinical Trials
-
The heart in inflammatory myopathies. Rheum Dis Clin North Am. 2014 Feb; 40(1):1-10.
Van Gelder H, Charles-Schoeman C. PMID: 24268006.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheumatol. 2014 Jan; 66(1):130-9.
McMahon M, Skaggs BJ, Grossman JM, Sahakian L, Fitzgerald J, Wong WK, Lourenco EV, Ragavendra N, Charles-Schoeman C, Gorn A, Karpouzas GA, Taylor MB, Watson KE, Weisman MH, Wallace DJ, Hahn BH. PMID: 24449580; PMCID: PMC4106468.
View in:
PubMed Mentions:
52 Fields:
Translation:
Humans
-
Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis. Arthritis Rheum. 2013 Nov; 65(11):2765-72.
Charles-Schoeman C, Lee YY, Shahbazian A, Gorn AH, Fitzgerald J, Ranganath VK, Taylor M, Ragavendra N, McMahon M, Elashoff D, Reddy ST. PMID: 23917967; PMCID: PMC4410876.
View in:
PubMed Mentions:
27 Fields:
Translation:
HumansCells
-
Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum. 2013 Jun; 65(6):1430-8.
Navarro-Millán I, Charles-Schoeman C, Yang S, Bathon JM, Bridges SL, Chen L, Cofield SS, Dell'Italia LJ, Moreland LW, O'Dell JR, Paulus HE, Curtis JR. PMID: 23460074; PMCID: PMC3672346.
View in:
PubMed Mentions:
68 Fields:
Translation:
Humans
-
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial. Lancet. 2013 Feb 09; 381(9865):451-60.
Burmester GR, Blanco R, Charles-Schoeman C, Wollenhaupt J, Zerbini C, Benda B, Gruben D, Wallenstein G, Krishnaswami S, Zwillich SH, Koncz T, Soma K, Bradley J, Mebus C, ORAL Step investigators. PMID: 23294500.
View in:
PubMed Mentions:
298 Fields:
Translation:
HumansCTClinical Trials
-
Cardiovascular disease and rheumatoid arthritis: an update. Curr Rheumatol Rep. 2012 Oct; 14(5):455-62.
Charles-Schoeman C. PMID: 22791398; PMCID: PMC3436948.
View in:
PubMed Mentions:
20 Fields:
Translation:
Humans
-
Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey. Clin Rheumatol. 2012 Aug; 31(8):1163-8.
Charles-Schoeman C, Amjadi SS, Paulus HE, International Myositis Assessment and Clinical Studies Group. PMID: 22526479.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 2012 Jul; 71(7):1157-62.
Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Ranganath VK, Taylor M, McMahon M, Paulus HE, Reddy ST. PMID: 22267330; PMCID: PMC3428121.
View in:
PubMed Mentions:
85 Fields:
Translation:
HumansAnimalsCells
-
Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis. Arthritis Rheum. 2012 Jun; 64(6):1828-37.
Watanabe J, Charles-Schoeman C, Miao Y, Elashoff D, Lee YY, Katselis G, Lee TD, Reddy ST. PMID: 22231638; PMCID: PMC3330163.
View in:
PubMed Mentions:
72 Fields:
Translation:
Humans
-
Nicotinamide adenine dinucleotide tetrazolium reductase identifies microvasculature activation in muscle from adult patients with dermatomyositis. J Rheumatol. 2012 Jan; 39(1):94-9.
Charles-Schoeman C, Verity MA. PMID: 22174214.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
View in:
PubMed Mentions:
39 Fields:
Translation:
HumansAnimalsCells
-
An association study of disease activity score components and patient satisfaction with overall health for early RA patients on non-biologic DMARD therapy. Rheumatol Int. 2012 Sep; 32(9):2725-9.
Kovalchik SA, Charles-Schoeman C, Khanna D, Paulus HE. PMID: 21805175.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis. 2011 Sep; 70(9):1619-24.
McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, Ragavendra N, Charles-Schoeman C, Chernishof M, Gorn A, Witztum JL, Wong WK, Weisman M, Wallace DJ, La Cava A, Hahn BH. PMID: 21670088; PMCID: PMC3147230.
View in:
PubMed Mentions:
49 Fields:
Translation:
HumansCells
-
Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. Circ J. 2011; 75(7):1533-8.
Imaizumi S, Navab M, Morgantini C, Charles-Schoeman C, Su F, Gao F, Kwon M, Ganapathy E, Meriwether D, Farias-Eisner R, Fogelman AM, Reddy ST. PMID: 21628835; PMCID: PMC3625624.
View in:
PubMed Mentions:
19 Fields:
Translation:
HumansAnimals
-
Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):258-65.
Volkmann ER, Grossman JM, Sahakian LJ, Skaggs BJ, FitzGerald J, Ragavendra N, Charles-Schoeman C, Chen W, Gorn A, Karpouzas G, Weisman M, Wallace DJ, Hahn BH, McMahon M. PMID: 20191526; PMCID: PMC2853476.
View in:
PubMed Mentions:
21 Fields:
Translation:
Humans
-
Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum. 2009 Oct; 60(10):2870-9.
Charles-Schoeman C, Watanabe J, Lee YY, Furst DE, Amjadi S, Elashoff D, Park G, McMahon M, Paulus HE, Fogelman AM, Reddy ST. PMID: 19790070; PMCID: PMC2828490.
View in:
PubMed Mentions:
75 Fields:
Translation:
Humans
-
Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum. 2009 Aug; 60(8):2428-37.
McMahon M, Grossman J, Skaggs B, Fitzgerald J, Sahakian L, Ragavendra N, Charles-Schoeman C, Watson K, Wong WK, Volkmann E, Chen W, Gorn A, Karpouzas G, Weisman M, Wallace DJ, Hahn BH. PMID: 19644959; PMCID: PMC2753974.
View in:
PubMed Mentions:
93 Fields:
Translation:
Humans
-
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis. Clin Immunol. 2008 May; 127(2):234-44.
Charles-Schoeman C, Banquerigo ML, Hama S, Navab M, Park GS, Van Lenten BJ, Wagner AC, Fogelman AM, Brahn E. PMID: 18337176.
View in:
PubMed Mentions:
28 Fields:
Translation:
HumansAnimalsCells
-
Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. J Rheumatol. 2007 Jul; 34(7):1459-64.
Charles-Schoeman C, Khanna D, Furst DE, McMahon M, Reddy ST, Fogelman AM, Paulus HE, Park GS, Gong T, Ansell BJ. PMID: 17552046.
View in:
PubMed Mentions:
44 Fields:
Translation:
Humans